Judith Robertson
Director/Board Member at DURECT CORPORATION
Net worth: 284 482 $ as of 2024-03-30
Profile
Judith J.
Robertson is an Independent Director at DURECT Corp.
since 2019 and the Chief Commercial Officer at Opthea Ltd.
since 2021.
Previously, she held positions such as Vice President-Sales & Marketing at Novartis, Inc. from 2006 to 2013, Vice President at Janssen Pharmaceuticals, Inc. from 2013 to 2016, Chief Commercial Officer at Aerie Pharmaceuticals, Inc. from 2016 to 2018, Vice President-Global Business Franchise at Alcon Laboratories, Inc., Head-Sales & Marketing at Viatris Holdings LLC, and Vice President-Immunology at Johnson & Johnson Services, Inc. She also served as the President of Bristol-Myers Squibb Canada Co. from 2001 to 2006.
Ms. Robertson's education includes an undergraduate degree from Toronto Metropolitan University and an MBA from Kellogg School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
OPTHEA LIMITED
0.08% | 2023-09-27 | 500,000 ( 0.08% ) | 241 390 $ | 2024-03-30 |
DURECT CORPORATION
0.12% | 2024-03-25 | 35,613 ( 0.12% ) | 43 092 $ | 2024-03-30 |
Judith Robertson active positions
| Companies | Position | Start |
|---|---|---|
| DURECT CORPORATION | Director/Board Member | 2019-04-22 |
| OPTHEA LIMITED | Corporate Officer/Principal | 2021-12-31 |
Former positions of Judith Robertson
| Companies | Position | End |
|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2018-11-30 |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Corporate Officer/Principal | 2016-10-31 |
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a private company based in San Francisco. | Sales & Marketing | 2013-05-31 |
Bristol-Myers Squibb Canada Co.
 Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Canada Co. designs, develops and wholesales pharmaceutical products. The company is headquartered in Halifax, Canada. | President | 2005-12-31 |
Training of Judith Robertson
| Toronto Metropolitan University of | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| DURECT CORPORATION | Health Technology |
| OPTHEA LIMITED | Health Technology |
| Private companies | 7 |
|---|---|
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a private company based in San Francisco. | Health Technology |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Health Technology |
| Viatris Holdings LLC | |
Johnson & Johnson Services, Inc.
 Johnson & Johnson Services, Inc. Pharmaceuticals: OtherHealth Technology Part of Johnson & Johnson, Johnson & Johnson Services, Inc. provides home and health care services. The private company is based in New Brunswick, NJ and was founded in 1886. | Health Technology |
Bristol-Myers Squibb Canada Co.
Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Canada Co. designs, develops and wholesales pharmaceutical products. The company is headquartered in Halifax, Canada. | Health Technology |
- Stock Market
- Insiders
- Judith Robertson
